Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment

OBJECTIVES: Treatments for SSc-associated interstitial lung disease (SSc-ILD) differ in attributes, i.e. mode of administration, adverse events (AEs) and efficacy. As physicians and patients may perceive treatments differently, shared decision-making can be essential for optimal treatment provision....

Descripción completa

Detalles Bibliográficos
Autores principales: Bruni, Cosimo, Heidenreich, Sebastian, Duenas, Ashley, Hoffmann-Vold, Anna-Maria, Gabrielli, Armando, Allanore, Yannick, Chatelus, Emmanuel, Distler, Jörg H W, Hachulla, Eric, Hsu, Vivien M, Hunzelmann, Nicolas, Khanna, Dinesh, Truchetet, Marie-Elise, Walker, Ulrich A, Alves, Margarida, Schoof, Nils, Saketkoo, Lesley Ann, Distler, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536797/
https://www.ncbi.nlm.nih.gov/pubmed/35238334
http://dx.doi.org/10.1093/rheumatology/keac126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536797/
https://www.ncbi.nlm.nih.gov/pubmed/35238334
http://dx.doi.org/10.1093/rheumatology/keac126

Ejemplares similares